Health Wire Syria: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 7, 2026

January 7, 2026

EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147

GlobeNewswire

January 7, 2026

FibroBiologics CEO Issues Letter to Shareholders

GlobeNewswire

January 7, 2026

Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108

GlobeNewswire

January 7, 2026

ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus

GlobeNewswire

January 7, 2026

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

GlobeNewswire

January 7, 2026

Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week

GlobeNewswire

January 7, 2026

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

GlobeNewswire

January 7, 2026

Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences

GlobeNewswire

January 7, 2026

Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards

GlobeNewswire

January 7, 2026

Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

4DMT Provides Company Update and Anticipated Development Milestones for 2026

GlobeNewswire

January 7, 2026

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

GlobeNewswire

January 7, 2026

Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support

GlobeNewswire

January 7, 2026

Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

Fulcrum Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

GlobeNewswire

January 7, 2026

Picard Medical Announces Conference Participation During J.P. Morgan Healthcare Conference Week

GlobeNewswire

January 7, 2026

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange

GlobeNewswire

January 7, 2026

Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

GlobeNewswire